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The likelihood that an older medical patient will be discharged
from hospital on the same medications upon which they were
admitted is less than 10%,1 with incomplete documentation of
changes in medication linked to preventable readmissions.2,3
Improved discharge information and patient education are core
principles for reducing unintentional medication changes, patient
harm and hospital re-admissions.4,5 In the United Kingdom (UK),
Medicines Use Reviews (MURs), face-to-face consultations between
a patient and their regular community pharmacist, are designed to
identify any problems or information needs patients have with
medicines and offer solutions.6 This service is free to National
Health Service (NHS) patients; pharmacists receive a fee (currently
£28) per MUR provided. Since 2011, the MUR service has targeted
speciﬁc patient groups, identiﬁed as being at particular risk of
medication related problems or poor adherence, including patients
recently discharged from hospital.6 Early evidence suggests uptake
of post discharge MURs (dMURs) has been poor.7,8
In 2012, a Department of Health steering group recommended
that formal communication channels between hospital and com-
munity pharmacy should be established so that dMURs become an
integral part of the medicines pathway.4 In light of the documented
medication problems that occur on transfer of care, a randomized
controlled feasibility study (the ‘Medicines Support Study’) was
devised to explore the effect a hospital referral system to older* Corresponding author. Pharmacy Department, Southport and Ormskirk NHS
Trust, Town Lane, Kew, Southport, PR8 6PN, UK.
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ings regarding problems in patient recruitment to the study and
community pharmacists' perceptions on delivering dMURs have
already been reported.9,10 This paper reports on the potential
clinical and economic impact of interventions made by the
pharmacists.2. Methods
All pharmacists working on medical wards at Southport and
Ormskirk Hospitals NHS Trust, England identiﬁed in-patients aged
over 65 years who, in their professional opinion, could beneﬁt from
a dMUR. Patients were given written information about the study
before being visited by the researcher (HR) who assessed eligibility
for recruitment. Inclusion and exclusion criteria have previously
been reported.9 Ethics approval for the studywas obtained from the
Northwest Research Ethics Committee (Ref 13/NW/0779).
Consenting patients were randomized to receive either a dMUR
or standard discharge care. A referral form and discharge pre-
scription for those to receive a dMUR was faxed to their nominated
community pharmacist to allow completion within 28 days as per
the national service speciﬁcation. Participating community phar-
macists were asked to share the ‘action plan’ on completion of each
dMUR with HR. This action plan included all advice given to the
patient and recommendations made to the patient's family doctor.
Each piece of advice given or recommendation madewas classed as
an intervention for the purposes of this study. Basic descriptive data
analysis on the numbers of dMURs completed and the manner in
which they were performed were conducted.
To assess the potential clinical impact of interventions made an
expert panel was convened and Delphi methodology used to arrive
at consensus. The term “expert” in this context has been described
as “clinicians practicing in the ﬁeld under consideration”.11 There-
fore the expert panel for this study comprised 5 pharmacists, 2
medical practitioners based in academia and 2 family doctors.
Consensus was deﬁned as 75% agreement between participants'
scores as advocated by Diamond et al.12 In addition, consensus can
also be achieved when stability of the distribution of scores oc-
curs.13,14 If variation between rounds is less than 15%, a state ofedicines use review (dMUR) service for older patients: Cost-savings
nd Administrative Pharmacy (2017), http://dx.doi.org/10.1016/
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the primary target, but also to consider the variance in scores if the
75% threshold was not reached.
All recorded interventions were collated and sent to panel
members via email to score independently. Participants were
instructed to award each intervention a value according to the
Eadon scoring criteria (Table 1).15 Space for free text comments was
provided after each statement, allowing participants to provide a
rationale for their positions.
Participants were asked to return their scores within twoweeks.
Reminder emails were sent at 2 and 4 weeks if no reply had been
received. If no response was obtained by week 6, that participant
was viewed as having left the process.
Following the return of scores, HR collated all scores and free-
text comments. Each participant then received a personalised
‘Round Two’ survey, with box plots showing their score along with
median and upper and lower quartiles for group scores. These
personalized surveys were then circulated to participants, returned
and analysed using the same process as for ‘Round One’.
Once consensus was achieved, the School of Health and Related
Research (ScHARR) model, used to apply an ‘opportunity cost’
saving to medication errors and adverse drug events avoided, was
mapped onto the Eadon score to determine the economic impact of
pharmacist interventions.16,173. Results
During the 9-month study, 30 patients were referred to their
regular community pharmacist, resulting in 20 dMURs conducted
(67% completion rate). Twelve (60%) were completed as per study
protocol (deﬁned as dMUR completion within 4 weeks of
discharge). The others were completed after 4 weeks, following one
or more prompts from HR.
Patients being unable to visit the pharmacy or being non-
contactable were the main reasons why dMURs were not
completed as per protocol, although some pharmacists reported
not receiving the original referral or this had been lost by the
pharmacy.
Action plans were returned for 17 of the 20 dMURs, generating
35 interventions. The most common type of intervention (n ¼ 14,
40%) was provision of information to improve their understanding
of why and how they were taking their medicines; the medical
condition for which the medicines were being used; how to avoid
side effects, or a combination. Six interventions (17%) involved
medicines reconciliation to ensure discrepancies between pre-
admission and discharge medications were intentional and un-
derstood. Four interventions resulted in the provision or recom-
mendation of a medication compliance aid (such as a monitored
dosage system or a spacer device to aid inhaler technique). A
further 4 involved patient referral for monitoring of their medica-
tion/condition. Three interventions involved provision of lifestyle
advice, for example regarding smoking cessation. The remaining 4
interventions included advice on how to obtain further supplies of
medication, referral to the family doctor for consideration ofTable 1
Eadon scoring system.
Intervention type
Intervention which is detrimental to the patients well-being
Intervention is of no signiﬁcance to patient care
Intervention is signiﬁcant but does not lead to an improvement in patien
Intervention is signiﬁcant and results in an improvement in the standard
Intervention is very signiﬁcant and prevents a major organ failure or adv
Intervention is potentially life-saving
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cation and referral to a specialist diabetes nurse.
3.1. Impact of pharmacist intervention
Five of the 35 reported interventions were very similar in nature
and for the purpose of the Delphi review were considered to be the
same intervention; hence 30 interventions in total were reviewed
by the panel.
Eight participants (all ﬁve pharmacists, both academic clinicians
and one of the two family doctors) returned Round One surveys,
and seven participants (all ﬁve pharmacists, one academic clinician
and one family doctor) returned Round Two surveys. Following
Round Two, greater than 75% agreement in scores was achieved for
5 of the 30 interventions, although 8 more achieved 71% agree-
ment. A further 8 achieved 57% agreement. When the percentage
change in mean scores between Rounds One and Two were
calculated, the variation was less than 10% for 28 of the 30 in-
terventions, and less than 15% for all but one. This indicated that
participants were not likely to alter their scores very much if a third
round was undertaken and at the risk of further drop-outs a further
round was not conducted.
None of the interventions made by community pharmacists
were found to be detrimental to the patient's wellbeing. Fifteen
interventions (50%) were assessed as being signiﬁcant and leading
to an improvement in patient care, whilst one intervention, where a
prescription for pre-admission medication was identiﬁed and
referred back to the doctor by the community pharmacist, was
graded as highly signiﬁcant and preventing major organ failure or
adverse reaction of similar importance (Table 2). This patient had
been diagnosed with heart failure during admission and had had
several changes to medicines including diuretics, anticoagulants,
beta-blockers and angiotensin converting enzyme inhibitors.
4. Discussion
In this feasibility study, two-thirds of participants received a
dMUR; more than twice that reported in a recent study of an
electronic referral (e-referral) system in Northeast England.18 The
higher completion rate in the current study may be because the
researcher contacted all community pharmacists at 4 weeks post
hospital referral to prompt completion of the dMUR. Such an
approach, whilst feasible in this study, is unlikely to be sustainable
on scale-up when accounting for secondary care pharmacy staff
workloads.9 However, the ability to build a ‘prompt’ into an e-
referral system may be a workable solution to help increase
completion rates.
In this study, the most common reason for non-completion at 4
weeks was patients' inability to visit the pharmacy, affecting almost
a quarter of participants. This was unexpected, as it was one of the
study exclusion criteria, and indicates that despite trying to screen
out this type of patient at recruitment, poor mobility affecting the
elderly post-discharge population is a major barrier to dMURs be-
ing conducted. The current national MUR service speciﬁcation andScore
1
2
t care 3
of care 4
erse reaction of similar importance 5
6
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Table 2
Eadon Scores and ScHARR cost avoidance associated with pharmacist interventions.
Eadon score ScHARR cost avoidance (£) Number of interventions Total cost avoidance (£)
2e3 0e6 14 0e84
4 65e150 15 975e2250
5 713e1484 1 713e1484
6 1085e2120 0 e
Overall Total Cost Avoidance £1688 - £3818
Cost Avoidance per dMURa £112.53 - £254.53
a Mean ¼ 2 interventions per dMUR.
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undertake MURs at patients' homes, so modiﬁcations are needed if
dMURs are to be routinely offered to this population.
Patients also failed to receive a dMUR as they were not con-
tactable by the community pharmacy. The reasons for this are
unclear, although within the study around one ﬁfth of patients
were re-admitted to hospital within four weeks of discharge, and
through participant interviews [not reported here], it was apparent
that patients had multiple appointments as part of their care
package post discharge. It is therefore possible that patients may
not have been at home at the times community pharmacists tried
to contact them. This does raise questions over co-ordination of
care by the various healthcare agencies involved in supporting
elderly patients discharged from hospital and the need for better
communication.
For those dMURs completed, an average of 2 interventions per
dMUR were instigated. Most commonly, interventions involved the
provision of information to improve patient understanding of their
medication and how to use it in the most effective, convenient and
safe way. This type of medicine support is in line with the ethos of
the MUR service as a whole. However, nearly one in ﬁve cases
required intervention to reconcile discrepancies between pre-
admission and discharge medications. These type of interventions
exemplify the ease with which misunderstandings can arise when
changes to medication occur during care transitions. Such mis-
understandings could result in inappropriate medicine taking and
further demonstrate the risks to patients during transfer of care.19
Following expert review, almost 60% of interventions were
deemed to improve clinical care. This is similar to the 53% reported
in Eadon's original (hospital-based) study, but lower than the 84%
reported during an analysis of the effect of consultant pharmacist
case management of older people in intermediate care.15,17 This
lower value is perhaps expected as, community pharmacists are
unlikely to possess the resources (in terms of specialist knowledge,
multidisciplinary team support, time for repeated follow-up and
ability to conduct home visits) afforded to a consultant pharmacist
in care of the elderly.
Assigning a monetary value to these interventions appears to
show a four-fold return on investment, even when using the most
conservative estimate of value delivered per dMUR conducted. This
ﬁgure does not however factor in hospital pharmacist time costs
associated with patient recruitment, referral and follow-up. The
staff costs in this study approximated to £42.44 for each referral
that resulted in a dMUR. After adding the MUR fee, the ﬁnal cost of
the service would be £70.44 per completed dMUR. This still rep-
resents a substantial cost saving to the NHS. Further cost savings
could be made if referrals were managed by pharmacy support
staff.18
The small number of patients in this study means ﬁndings need
to be interpreted with caution. Additionally, interventions studied
were not outcomes in themselves, and their conversion into cost
savings is an estimation, as it is difﬁcult to demonstrate a direct
effect of the interventions made. However, the use of the Eadon-Please cite this article in press as: Ramsbottom H, et al., Post discharge m
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to each intervention provides an insight into the effect of these
interventions on patient care. It should also be noted that using a
Delphi process to gain consensus is still based on subjective
opinion.13 This is particularly pertinent here as, consensus
regarding the score to award the majority of interventions was
deﬁned by stability in the opinions of the reviewers, not agreement
as to the score awarded.
A larger study involving more interventions would help to
validate these results, and if potential clinical signiﬁcance and cost
avoidance could be linked to other outcomes such as reduced
readmission rates, this would help to demonstrate causality of the
intervention on improvements in these outcomes.
5. Conclusion
This study shows the potential for improved patient care and a
positive return on investment when community pharmacists
perform dMURs. However, operational barriers exist to delivering
dMURs to the frail elderly and there is a need to improve
communication channels between health care practitioners to
deliver a holistic package of care post discharge.
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